Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunity Persistence of Live Attenuated Varicella Vaccine
NCT05095701Phase 4Enrolling by invitation
- Sponsor
- Sinovac Biotech Ltd.
- Start
- Dec 2021
- Primary completion
- Dec 2021
- Modality
- Prophylactic Vaccines, DNA Vaccines, Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 4 trial of varicella vaccine live in varicella (VZV), sponsored by Sinovac Biotech Ltd.. Started Dec 2021; status: enrolling by invitation.
02
Drugs
varicella vaccine live
03
Conditions
varicella (VZV)
Beyond the preview
Go deeper on NCT05095701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05095701.